Latest filing published 20 Feb 2026 for Sagimet Biosciences Inc..
No signal scores available.
Thierry Chauche appears in our data through filings on Sagimet Biosciences Inc. shares, published by SEC (Form 4). Between 6 February 2025 and 19 February 2026, the trades on record add up to 3 filings.
No open-market purchase appears, only 1 sale worth €5,908. The rest of the record consists of 2 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 20 February 2026 with a share grant in Sagimet Biosciences Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations